Publication | Closed Access
A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer.
43
Citations
4
References
2009
Year
Oral vinorelbine-capecitabine shows very promising activity and low toxicity in MBC treatment, with high compliance of the patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1